Treatment for reducing adverse events including chemotherapy discomfort and other conditions

Abstract

This disclosure relates to treatments for reducing the side effects associated with treatment of a medication or drug, such as a chemotherapy medication, being experienced by a patient. This may be accomplished by administering to a patient taking the medication, a buffered aqueous liquid having a pH of about 10 to about 11.5.

1 . A method for reducing an adverse event associated with use of a medication, comprising: administering to a patient taking the medication, a buffered aqueous liquid having a pH of about 10 to about 11.5. 
     
     
         2 . The method of  claim 1 , wherein the buffered aqueous liquid comprises a bicarbonate. 
     
     
         3 . The method of  claim 2 , wherein the buffered aqueous liquid comprises an additional buffering compound. 
     
     
         4 . The method of  claim 1 , wherein the buffered aqueous liquid comprises a carbonate. 
     
     
         5 . The method of  claim 4 , wherein the buffered aqueous liquid comprises an additional buffering compound. 
     
     
         6 . The method of  claim 1 , wherein the buffered aqueous liquid comprises a phosphate. 
     
     
         7 . The method of  claim 6 , wherein the buffered aqueous liquid comprises an additional buffering compound. 
     
     
         8 . The method of  claim 1 , wherein the buffered aqueous liquid comprises sodium bicarbonate, sodium carbonate, and trisodium phosphate. 
     
     
         9 . The method of  claim 8 , wherein the sodium bicarbonate is about 14% to about 25%, the sodium carbonate is about 25% to about 35%, and the trisodium phosphate is about 45% to about 55% of the weight of the total amount of sodium bicarbonate, sodium carbonate, and trisodium phosphate that is present in the buffered aqueous liquid. 
     
     
         10 . The method of  claim 1 , wherein the medication is a chemotherapy medication. 
     
     
         11 . The method of  claim 1 , wherein the buffered aqueous liquid is orally administered to the patient three times per waking day. 
     
     
         12 . The method of  claim 10 , wherein the buffered aqueous liquid is administered separately from the medication that the patient is receiving. 
     
     
         13 . The method of  claim 1 , wherein the buffered aqueous liquid is administered orally. 
     
     
         14 . The method of  claim 1 , wherein each gallon of the buffered aqueous liquid contains about 64 grams total of the sodium bicarbonate, the sodium carbonate, and the trisodium phosphate. 
     
     
         15 . The method of  claim 1 , wherein the buffered aqueous liquid is orally administered to the patient in about 0.2-ounce to about 2-ounce increments three times per waking day, wherein the increments are spaced at intervals of about 4 to about 6 hours.